Platelet-derived growth factor-AA increases IL-1β and IL-8 expression and activates NF-κB in rheumatoid fibroblast-like synoviocytes

Scandinavian Journal of Immunology

Volumn 60, Issue 5, 2004, Pages 455-462

  Cheon, H ^a,b   Sun, Y K ^a   Yu, S J ^a,b   Lee, Y H ^a   Ji, J D ^a   Song, G G ^a   Lee, J H ^a   Kim, M K ^a   Sohn, J ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SUPERNATANT; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MACROPHAGE INFLAMMATORY PROTEIN-1; NF-KAPPA B; PLATELET-DERIVED GROWTH FACTOR; SYNOVIAL MEMBRANE;

EID: 8444237393     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01505.x     Document Type: Article

References (31)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
2. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
3. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
4. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999;401:86-90.
5. Gilbertson DG, Duff ME, West JW et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 2001;276:27406-14.
6. Bergsten E, Uutela M, Li X et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta- receptor. Nat Cell Biol 2001;3:512-6.
7. Watanabe N, Ando K, Yoshida S et al. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the over-expression of genes responsible for tumor-like growth of rheumatoid synovium. Biochem Biophys Res Commun 2002;294:1121-9.
8. Ridderstad A, Abedi-Valugerdi M, Moller E. Cytokines in rheumatoid arthritis. Ann Med 1991;23:219-23.
9. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
10. Cheon H, Yu SY, Yoo DH, Chae IJ, Song GG, Sohn J. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-betal in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol 2002;127:547-52.
11. Goddard DH, Grossman SL, Newton R. Polypeptide growth factors augment interleukin 1-induced release of prostaglandin E2 by rheumatoid arthritis synovial cells in vitro. Cytokine 1990;2: 294-9.
12. Chen QR, Miyaura C, Higashi S et al. Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. J Biol Chem 1997;272:5952-8.
13. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989;243:393-6.
14. Bonner JC, Lindroos PM, Rice AB, Moomaw CR, Morgan DL. Induction of PDGF receptor-alpha in rat myofibroblasts during pulmonary fibrogenesis in vivo. Am J Physiol 1998;274:L72-80.
15. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001;107: 1529-36.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
17. Gery I, Waksman BH. Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediators. J Exp Med 1972;136:143-55.
18. Beausejour A, Deslauriers N, Grenier D. Activation of the Interleukin-1β precursor by Treponema denticola: a potential role in chronic inflammatory peridontal diseases. Infect Immun 1997;65:3199-202.
19. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37 (5):644-52.
20. Remmers EF, Lafyatis R, Kumkumian GK et al. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors 1990;2:179-88.
21. Reuterdahl C, Tingstrom A, Terracio L, Funa K, Heldin CH, Rubin K. Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium. Lab Invest 1991;64:321-9.
22. Moss V, Picker S, Muller B, Weber U, Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 1999;26:870-9.
23. Dayer JM. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2003;42 (Suppl. 2):ii3-10.
24. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBOJ 1991;10:4025-31.
25. Paleolog E. The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis. Expert Opin Investig Drugs 2003;12: 1087-95.
26. Taylor PC. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 2003;9:1095-106.
27. Marok R, Winyard PG, Coumbe A et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583-91.
28. Asahara H, Asanuma M, Ogawa N, Nishibayashi S, Inoue H. High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis. Biochem Mol Biol Int 1995;37:827-32.
29. Bondeson J, Foxwell B, Brenan F, Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci USA 1999;96:5668-73.
30. Tomita T, Takeuchi E, Tomita N et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 1999;42:2532-42.
31. Miagkov AV, Kovalenko DV, Brown CE et al. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Nad Acad Sci USA 1998;95:13859-64.